KEGG   DRUG: Levodopa and benserazide hydrochloride
Entry
D02135            Mixture   Drug                                   
Name
Levodopa and benserazide hydrochloride;
Madopar (TN)
Component
Levodopa [DR:D00059], Benserazide hydrochloride [DR:D01653]
Class
Neuropsychiatric agent
 DG01967  Antiparkinson agent
Remark
Therapeutic category: 1169
ATC code: N04BA02
Product: D02135<JP>
Efficacy
Antiparkinsonian
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 N NERVOUS SYSTEM
  N04 ANTI-PARKINSON DRUGS
   N04B DOPAMINERGIC AGENTS
    N04BA Dopa and dopa derivatives
     N04BA02 Levodopa and decarboxylase inhibitor
      D02135  Levodopa and benserazide hydrochloride <JP>
Therapeutic category of drugs in Japan [BR:br08301]
 1  Agents affecting nervous system and sensory organs
  11  Agents affecting central nervous system
   116  Antiparkinsonian agents
    1169  Others
     D02135  Levodopa and benserazide hydrochloride
Drug groups [BR:br08330]
 Neuropsychiatric agent
  DG01967  Antiparkinson agent
   D02135  Levodopa and benserazide hydrochloride
Drug classes [BR:br08332]
 Neuropsychiatric agent
  DG01967  Antiparkinson agent
   D02135  Levodopa and benserazide hydrochloride
Other DBs
PubChem: 7849196
LigandBox: D02135
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system